Tokyo, Japan

Chikashi Hirashima

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Chikashi Hirashima: Innovator in Immunoglobulin Production

Introduction

Chikashi Hirashima is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of glycosylated immunoglobulins. With a total of 5 patents to his name, Hirashima's work has advanced the understanding and methods of immunoglobulin production.

Latest Patents

Hirashima's latest patent focuses on a method for the production of a glycosylated immunoglobulin. This innovative method involves several key steps: first, providing a eukaryotic cell that contains a nucleic acid encoding the immunoglobulin. Next, the eukaryotic cell is cultivated in a medium where the glucose available is kept constant and limited to less than 80% of the maximum amount that the cells can utilize per time unit. Finally, the immunoglobulin is recovered from the culture. This method represents a significant advancement in the efficient production of immunoglobulins.

Career Highlights

Throughout his career, Chikashi Hirashima has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Chugai Pharmaceutical Co., Ltd. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Hirashima has collaborated with several professionals in his field, including Shinya Takuma and Reinhard Franze. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Chikashi Hirashima is a distinguished inventor whose work in the production of glycosylated immunoglobulins has made a significant impact in biotechnology. His patents and collaborations reflect his commitment to advancing scientific knowledge and innovation in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…